{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T01:09:47Z","timestamp":1794877787766,"version":"4.9.1"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck & Co Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.neuroscience.2021.03.003","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T06:14:30Z","timestamp":1616048070000},"page":"30-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The Dual Orexin Receptor Antagonist DORA-22 Improves Mild Stress-induced Sleep Disruption During the Natural Sleep Phase of Nocturnal Rats"],"prefix":"10.1016","volume":"463","author":[{"given":"Mackenzie C.","family":"Gamble","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumi","family":"Katsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Strecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.neuroscience.2021.03.003_b0005","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s40266-018-0569-8","article-title":"Insomnia in elderly patients: Recommendations for pharmacological management","volume":"35","author":"Abad","year":"2018","journal-title":"Drugs Aging"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0010","doi-asserted-by":"crossref","unstructured":"Arand DL, Bonnet MH. The multiple sleep latency test. In: Handbook of clinical neurology. Vol 160. Elsevier B.V.; 2019:393-403. doi:10.1016\/B978-0-444-64032-1.00026-6","DOI":"10.1016\/B978-0-444-64032-1.00026-6"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neuropharm.2014.09.012","article-title":"Both Ox1r and Ox2r orexin receptors contribute to the cardiovascular and locomotor components of the novelty stress response in the rat","volume":"89","author":"Beig","year":"2015","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.neuroscience.2021.03.003_b0020","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsz076","article-title":"Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep\/wake regulation","volume":"42","author":"Beuckmann","year":"2019","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.neuroscience.2021.03.003_b0025","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1124\/jpet.114.220392","article-title":"A selective orexin-1 receptor antagonist attenuates stress-induced hyperarousal without hypnotic effects","volume":"352","author":"Bonaventure","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.neuroscience.2021.03.003_b0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nm1544","article-title":"Promotion of sleep by targeting the orexin system in rats, dogs and humans","volume":"13","author":"Brisbare-Roch","year":"2007","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.neuroscience.2021.03.003_b0040","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1152\/physrev.00032.2011","article-title":"Control of sleep and wakefulness","volume":"92","author":"Brown","year":"2012","journal-title":"Physiol Rev"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0045","doi-asserted-by":"crossref","unstructured":"Callander GE, Olorunda M, Monna D, et al. Kinetic properties of \u201cdual\u201d orexin receptor antagonists at OX1R and OX2R orexin receptors. Front Neurosci. 2013;7(7 DEC):230. doi:10.3389\/fnins.2013.00230.","DOI":"10.3389\/fnins.2013.00230"},{"issue":"40","key":"10.1016\/j.neuroscience.2021.03.003_b0050","doi-asserted-by":"crossref","first-page":"10167","DOI":"10.1523\/JNEUROSCI.1809-08.2008","article-title":"Neural circuitry of stress-induced insomnia in rats","volume":"28","author":"Cano","year":"2008","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.neuroscience.2021.03.003_b0055","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1677\/joe.0.1440311","article-title":"The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat","volume":"144","author":"Carey","year":"1995","journal-title":"J Endocrinol"},{"issue":"2","key":"10.1016\/j.neuroscience.2021.03.003_b0060","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2466\/pms.1979.48.2.495","article-title":"Effects of total sleep loss on sleep tendency","volume":"48","author":"Carskadon","year":"1979","journal-title":"Percept Mot Skills"},{"issue":"4","key":"10.1016\/j.neuroscience.2021.03.003_b0065","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2869.2008.00698.x","article-title":"24 hours of sleep deprivation in the rat increases sleepiness and decreases vigilance: Introduction of the rat-psychomotor vigilance task","volume":"17","author":"Christie","year":"2008","journal-title":"J Sleep Res"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2020.101332","article-title":"Effects of orexin receptor antagonism on human sleep architecture: A systematic review","volume":"53","author":"Clark","year":"2020","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0075","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-pharmtox-010716-104837","article-title":"The discovery of suvorexant, the first orexin receptor drug for insomnia","volume":"57","author":"Coleman","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0080","doi-asserted-by":"crossref","unstructured":"De Lecea L, Kilduff TS, Peyron C, et al 1998 The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A, 95:322-327. doi:10.1073\/pnas.95.1.322.","DOI":"10.1073\/pnas.95.1.322"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0085","doi-asserted-by":"crossref","unstructured":"De Lecea L (2012) Hypocretins and the neurobiology of sleep-wake mechanisms. In Progress in brain research. Vol 198. Elsevier B.V.; 15-24. doi:10.1016\/B978-0-444-59489-1.00003-3.","DOI":"10.1016\/B978-0-444-59489-1.00003-3"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-3-642-69659-6_2","article-title":"Issues in the diagnosis and treatment of insomnia","volume":"1","author":"Dement","year":"1984","journal-title":"Psychopharmacology Suppl"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0095","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fnsys.2014.00046","article-title":"Sleep for cognitive enhancement","volume":"8","author":"Diekelmann","year":"2014","journal-title":"Front Syst Neurosci"},{"issue":"2","key":"10.1016\/j.neuroscience.2021.03.003_b0100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-010-1933-5","article-title":"Intact learning and memory in rats following treatment with the dual orexin receptor antagonist almorexant","volume":"212","author":"Dietrich","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0105","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3389\/fnins.2020.625397","article-title":"Neurobiological and hormonal mechanisms regulating women\u2019s sleep","volume":"14","author":"Dorsey","year":"2021","journal-title":"Front Neurosci"},{"issue":"1","key":"10.1016\/j.neuroscience.2021.03.003_b0110","first-page":"17","article-title":"The effects of routine cage-changing on cardiovascular and behavioral parameters in male sprague-dawley rats","volume":"40","author":"Duke","year":"2001","journal-title":"Contemp Top Lab Anim Sci"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0115","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.trci.2019.01.003","article-title":"Effects of the dual orexin receptor antagonist DORA-22 on sleep in 5XFAD mice","volume":"5","author":"Duncan","year":"2019","journal-title":"Alzheimers Dement (N Y)."},{"issue":"1","key":"10.1016\/j.neuroscience.2021.03.003_b0120","first-page":"29","article-title":"Effects of housing condition and cage change on characteristics of sleep in mice","volume":"53","author":"Febinger","year":"2014","journal-title":"J Am Assoc Lab Anim Sci"},{"issue":"5","key":"10.1016\/j.neuroscience.2021.03.003_b0125","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.neubiorev.2010.12.003","article-title":"The function of the sleep spindle: A physiological index of intelligence and a mechanism for sleep-dependent memory consolidation","volume":"35","author":"Fogel","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"issue":"12","key":"10.1016\/j.neuroscience.2021.03.003_b0130","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1038\/npp.2013.139","article-title":"Quantitative electroencephalography within sleep\/wake states differentiates GABA A modulators eszopiclone and zolpidem from dual orexin receptor antagonists in rats","volume":"38","author":"Fox","year":"2013","journal-title":"Neuropsychopharmacology."},{"issue":"3","key":"10.1016\/j.neuroscience.2021.03.003_b0135","article-title":"The dual orexinergic receptor antagonist DORA-22 improves the sleep disruption and memory impairment produced by a rodent insomnia model","volume":"43","author":"Gamble","year":"2020","journal-title":"Sleep"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.conb.2014.07.006","article-title":"Hypocretin (orexin) neuromodulation of stress and reward pathways","volume":"29","author":"Giardino","year":"2014","journal-title":"Curr Opin Neurobiol"},{"issue":"1","key":"10.1016\/j.neuroscience.2021.03.003_b0145","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2202-15-109","article-title":"Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulators","volume":"15","author":"Gotter","year":"2014","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuroscience.2021.03.003_b0150","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2202-14-90","article-title":"The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold","volume":"14","author":"Gotter","year":"2013","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuroscience.2021.03.003_b0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev-neuro-062012-170429","article-title":"Sleep for preserving and transforming episodic memory","volume":"36","author":"Inostroza","year":"2013","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0160","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3389\/fnbeh.2018.00327","article-title":"Orexin receptor blockade-induced sleep preserves the ability to wake in the presence of threat in mice","volume":"12","author":"Iwakawa","year":"2018","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0165","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/7854_2016_47","article-title":"Orexin OX2 receptor antagonists as sleep aids","volume":"33","author":"Jacobson","year":"2017","journal-title":"Curr Top Behav Neurosci."},{"issue":"12","key":"10.1016\/j.neuroscience.2021.03.003_b0170","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1046\/j.1365-2826.2000.00572.x","article-title":"Effects of orexins on the hypothalamic-pituitary-adrenal system","volume":"12","author":"J\u00e1szber\u00e9nyi","year":"2000","journal-title":"J Neuroendocrinol"},{"issue":"2","key":"10.1016\/j.neuroscience.2021.03.003_b0175","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/sleep\/13.2.121","article-title":"Daytime sleepiness, performance, mood, nocturnal sleep: The effect of benzodiazepine and caffeine on their relationship","volume":"13","author":"Johnson","year":"1990","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.neuroscience.2021.03.003_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsmc.2017.09.001","article-title":"Sleep in normal aging","volume":"13","author":"Li","year":"2018","journal-title":"Sleep Med Clin"},{"issue":"4","key":"10.1016\/j.neuroscience.2021.03.003_b0185","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0005-7967(02)00023-2","article-title":"Quantitative criteria for insomnia","volume":"41","author":"Lichstein","year":"2003","journal-title":"Behav Res Ther"},{"issue":"4","key":"10.1016\/j.neuroscience.2021.03.003_b0190","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/sleep\/29.4.479","article-title":"Defining insomnia: Quantitative criteria for insomnia severity and frequency","volume":"29","author":"Lineberger","year":"2006","journal-title":"Sleep"},{"issue":"6","key":"10.1016\/j.neuroscience.2021.03.003_b0195","doi-asserted-by":"crossref","first-page":"zsz302","DOI":"10.1093\/sleep\/zsz302","article-title":"Dual orexin receptor antagonists increase sleep and cataplexy in wild type mice","volume":"43","author":"Mahoney","year":"2020","journal-title":"Sleep"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0200","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-clinpsy-050718-095754","article-title":"Abnormal sleep spindles, memory consolidation, and schizophrenia","volume":"15","author":"Manoach","year":"2019","journal-title":"Annu Rev Clin Psychol"},{"issue":"1","key":"10.1016\/j.neuroscience.2021.03.003_b0205","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/cne.1190","article-title":"Differential expression of Orexin receptors 1 and 2 in the rat brain","volume":"435","author":"Marcus","year":"2001","journal-title":"J Comp Neurol"},{"issue":"3","key":"10.1016\/j.neuroscience.2021.03.003_b0210","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0306-4522(99)00045-7","article-title":"Influence of stress duration on the sleep rebound induced by immobilization in the rat: a possible role for corticosterone","volume":"92","author":"Marinesco","year":"1999","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.neuroscience.2021.03.003_b0215","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.sleep.2007.03.005","article-title":"Neurobiology of REM and NREM sleep","volume":"8","author":"McCarley","year":"2007","journal-title":"Sleep Med"},{"issue":"4","key":"10.1016\/j.neuroscience.2021.03.003_b0220","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.neuroscience.2007.03.009","article-title":"Sleep fragmentation elevates behavioral, electrographic and neurochemical measures of sleepiness","volume":"146","author":"McKenna","year":"2007","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.neuroscience.2021.03.003_b0225","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2869.2008.00686.x","article-title":"Assessing sleepiness in the rat: A multiple sleep latencies test compared to polysomnographic measures of sleepiness","volume":"17","author":"McKenna","year":"2008","journal-title":"J Sleep Res"},{"issue":"2","key":"10.1016\/j.neuroscience.2021.03.003_b0230","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.12792","article-title":"A rodent cage change insomnia model disrupts memory consolidation","volume":"28","author":"McKenna","year":"2019","journal-title":"J Sleep Res"},{"issue":"8","key":"10.1016\/j.neuroscience.2021.03.003_b0235","first-page":"26","article-title":"Orexin 1 receptor antagonists in compulsive behavior and anxiety: possible therapeutic use","volume":"13","author":"Merlo Pich","year":"2014","journal-title":"Front Neurosci"},{"issue":"10","key":"10.1016\/j.neuroscience.2021.03.003_b0240","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.5665\/SLEEP.1272","article-title":"Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects","volume":"34","author":"Mets","year":"2011","journal-title":"Sleep"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146461","article-title":"Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil","volume":"1731","author":"Mohammadkhani","year":"2020","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fnins.2014.00003","article-title":"The hypocretin\/orexin antagonist almorexant promotes sleep without impairment of performance in rats","volume":"8","author":"Morairty","year":"2014","journal-title":"Front Neurosci"},{"issue":"4","key":"10.1016\/j.neuroscience.2021.03.003_b0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000341","article-title":"Daytime naps, motor memory consolidation and regionally specific sleep spindles","volume":"2","author":"Nishida","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0260","doi-asserted-by":"crossref","unstructured":"O\u2019Connor SL, JFragale JE, James MH, Aston-Jones G. The dual orexin\/hypocretin receptor antagonist suvorexant reduces addiction-like behaviors for the opioid fentanyl. bioRxiv 2020; 04.25.061887; doi: 10.1101\/2020.04.25.061887.","DOI":"10.1101\/2020.04.25.061887"},{"issue":"23","key":"10.1016\/j.neuroscience.2021.03.003_b0265","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.neuroscience.2021.03.003_b0270","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1152\/physiol.00062.2015","article-title":"Sleep neurophysiological dynamics through the lens of multitaper spectral analysis","volume":"32","author":"Prerau","year":"2017","journal-title":"Physiology"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0275","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fnins.2013.00254","article-title":"Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulators","volume":"7","author":"Ramirez","year":"2013","journal-title":"Front Neurosci"},{"issue":"4","key":"10.1016\/j.neuroscience.2021.03.003_b0280","first-page":"479","article-title":"Cage change influences serum corticosterone and anxiety-like behaviors in the mouse","volume":"50","author":"Rasmussen","year":"2011","journal-title":"J Am Assoc Lab Anim Sci"},{"issue":"4","key":"10.1016\/j.neuroscience.2021.03.003_b0285","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0013-4694(82)90009-8","article-title":"Application of the multiple sleep latency test in disorders of excessive sleepiness","volume":"53","author":"Reynolds","year":"1982","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"5","key":"10.1016\/j.neuroscience.2021.03.003_b0290","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/2042098615595359","article-title":"Suvorexant in insomnia: efficacy, safety and place in therapy","volume":"6","author":"Rhyne","year":"2015","journal-title":"Ther Adv Drug Saf"},{"issue":"2","key":"10.1016\/j.neuroscience.2021.03.003_b0295","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1021\/acs.jmedchem.5b00832","article-title":"Orexin receptor antagonists: new therapeutic agents for the treatment of insomnia","volume":"59","author":"Roecker","year":"2016","journal-title":"J Med Chem"},{"issue":"8","key":"10.1016\/j.neuroscience.2021.03.003_b0300","first-page":"617","article-title":"Insomnia risks and costs: Health, safety, and quality of life","volume":"16","author":"Rosekind","year":"2010","journal-title":"Am J Manage Care"},{"issue":"4","key":"10.1016\/j.neuroscience.2021.03.003_b0305","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0310","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuropharm.2018.09.034","article-title":"The role of the orexin system in stress response","volume":"154","author":"Sargin","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0315","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev-pharmtox-010510-100528","article-title":"Orexin receptors: Pharmacology and therapeutic opportunities","volume":"51","author":"Scammel","year":"2011","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"10.1016\/j.neuroscience.2021.03.003_b0320","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.neuron.2017.01.014","article-title":"Neural circuitry of wakefulness and sleep","volume":"93","author":"Scammell","year":"2017","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.neuroscience.2021.03.003_b0325","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/nn1005-1286","article-title":"Orexin, drugs and motivated behaviors","volume":"8","author":"Scammell","year":"2005","journal-title":"Nat Neurosci"},{"issue":"4","key":"10.1016\/j.neuroscience.2021.03.003_b0330","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s40265-020-01276-1","article-title":"Lemborexant: first approval","volume":"80","author":"Scott","year":"2020","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.neuroscience.2021.03.003_b0335","first-page":"8","article-title":"Stress-like responses to common procedures in male rats housed alone or with other rats","volume":"41","author":"Sharp","year":"2002","journal-title":"Contemp Top Lab Anim Sci"},{"issue":"4","key":"10.1016\/j.neuroscience.2021.03.003_b0340","first-page":"15","article-title":"Stress-like responses to common procedures in rats: effect of the estrous cycle","volume":"41","author":"Sharp","year":"2002","journal-title":"Contemp Top Lab Anim Sci"},{"issue":"25","key":"10.1016\/j.neuroscience.2021.03.003_b0345","doi-asserted-by":"crossref","first-page":"10288","DOI":"10.1073\/pnas.1308295110","article-title":"Behavioral and biochemical dissociation of arousal and homeostatic sleep need influenced by prior wakeful experience in mice","volume":"110","author":"Suzuki","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.neuroscience.2021.03.003_b0350","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsx178","article-title":"Insight into reduction of wakefulness by suvorexant in patients with insomnia: Analysis of wake bouts","volume":"41","author":"Svetnik","year":"2018","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.neuroscience.2021.03.003_b0355","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bbr.2004.11.015","article-title":"Rat strain differences in sleep after acute mild stressors and short-term sleep loss","volume":"160","author":"Tang","year":"2005","journal-title":"Behav Brain Res"},{"issue":"4","key":"10.1016\/j.neuroscience.2021.03.003_b0360","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.physbeh.2005.05.008","article-title":"Differential effects of two types of environmental novelty on activity and sleep in BALB\/cJ and C57BL\/6J mice","volume":"85","author":"Tang","year":"2005","journal-title":"Physiol Behav"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0365","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.brainres.2007.01.029","article-title":"Interactions between brief restraint, novelty and footshock stress on subsequent sleep and EEG power in rats","volume":"1142","author":"Tang","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0370","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fnbeh.2014.00182","article-title":"Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogs","volume":"8","author":"Tannenbaum","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0375","doi-asserted-by":"crossref","unstructured":"Tannenbaum PL, Tye SJ, Stevens J, Gotter AL, Fox SV, Savitz AT, Coleman PJ, Uslaner JM, Kuduk SD, Hargreaves R, Winrow CJ, Renger JJ. Inhibition of orexin signaling promotes sleep yet preserves salient arousability in monkeys. Sleep. 2016;39(3):603-12. doi: 10.5665\/sleep.5536","DOI":"10.5665\/sleep.5536"},{"issue":"1","key":"10.1016\/j.neuroscience.2021.03.003_b0380","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-40398-9","article-title":"Thalamic reticular nucleus parvalbumin neurons regulate sleep spindles and electrophysiological aspects of schizophrenia in mice","volume":"9","author":"Thankachan","year":"2019","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.neuroscience.2021.03.003_b0385","first-page":"91","article-title":"Animal models of sleep disorders","volume":"63","author":"Toth","year":"2013","journal-title":"Comp Med"},{"issue":"179","key":"10.1016\/j.neuroscience.2021.03.003_b0390","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005213","article-title":"Orexin receptor antagonists differ from standard sleep drugs by promoting sleep at doses that do not disrupt cognition","volume":"5","author":"Uslaner","year":"2013","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.neuroscience.2021.03.003_b0395","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsy218","article-title":"Validation of an automated sleep spindle detection method for mouse electroencephalography","volume":"42","author":"Uygun","year":"2019","journal-title":"Sleep"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0400","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bbr.2014.10.028","article-title":"The orexin-1 receptor antagonist SB-334867 decreases anxiety-like behavior and c-Fos expression in the hypothalamus of rats exposed to cat odor","volume":"278","author":"Vanderhaven","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0405","doi-asserted-by":"crossref","unstructured":"Vermeeren A, Coenen AML 2011 Effects of the use of hypnotics on cognition. In Progress in brain research. Vol 190. Elsevier B.V.; 89-103. doi:10.1016\/B978-0-444-53817-8.00005-0","DOI":"10.1016\/B978-0-444-53817-8.00005-0"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0410","doi-asserted-by":"crossref","unstructured":"Vermeeren A, Vets E, Vuurman EF, Van Oers AC, Jongen S, Laethem T, Heirman I, Bautmans A, Palcza J, Li X, Troyer MD, Wrishko R, McCrea J, Sun H. On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly. Psychopharmacology (Berl). 2016;233(18):3341-51. doi: 10.1007\/s00213-016-4375-x","DOI":"10.1007\/s00213-016-4375-x"},{"key":"10.1016\/j.neuroscience.2021.03.003_b0415","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.brainres.2009.07.064","article-title":"Spatial learning and memory deficits following exposure to 24 h of sleep fragmentation or intermittent hypoxia in a rat model of obstructive sleep apnea","volume":"1294","author":"Ward","year":"2009","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.neuroscience.2021.03.003_b0420","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/bph.12261","article-title":"Discovery and development of orexin receptor antagonists as therapeutics for insomnia","volume":"171","author":"Winrow","year":"2014","journal-title":"Br J Pharmacol"},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2021.03.003_b0425","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/01677063.2011.566953","article-title":"Promotion of sleep by Suvorexant - A novel dual orexin receptor antagonist","volume":"25","author":"Winrow","year":"2011","journal-title":"J Neurogenet"},{"issue":"2","key":"10.1016\/j.neuroscience.2021.03.003_b0430","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.neuropharm.2011.10.003","article-title":"Pharmacological characterization of MK-6096 - A dual orexin receptor antagonist for insomnia","volume":"62","author":"Winrow","year":"2012","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.neuroscience.2021.03.003_b0435","doi-asserted-by":"crossref","first-page":"e206614","DOI":"10.1001\/jamanetworkopen.2020.6614","article-title":"Effect of suvorexant vs placebo on total daytime sleep hours in shift workers: a randomized clinical trial","volume":"3","author":"Zeitzer","year":"2020","journal-title":"JAMA Netw Open"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452221001196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452221001196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:04:09Z","timestamp":1759680249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452221001196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":86,"alternative-id":["S0306452221001196"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2021.03.003","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Dual Orexin Receptor Antagonist DORA-22 Improves Mild Stress-induced Sleep Disruption During the Natural Sleep Phase of Nocturnal Rats","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2021.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd on behalf of IBRO.","name":"copyright","label":"Copyright"}]}}